Loading publications…
The last 5 uploaded publications
DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma
Augusto Villanueva, Anna Portela, Sergi Sayols, Carlo Battiston, Yujin Hoshida, Jesús Méndez‐González, Sandrine Imbeaud, Éric Letouzé, Virginia Hernández‐Gea, Helena Cornellà, Roser Pinyol, Manel Solé, Josep Fuster, Jessica Zucman‐Rossi, Vincenzo Mazzaferro, Manel Esteller, Josep M. Llovet (2015). DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma. Hepatology, 61(6), pp. 1945-1956, DOI: 10.1002/hep.27732.
Article145 days agoIGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models
Iris Martinez-Quetglas, Roser Pinyol, Daniel Dauch, Sara Torrecilla, Victoria Tovar, Agrin Moeini, Clara Alsinet, Anna Portela, Leonardo Rodríguez‐Carunchio, Manel Solé, Amaia Lujambio, Augusto Villanueva, Swan N. Thung, Manel Esteller, Lars Zender, Josep M. Llovet (2016). IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models. Gastroenterology, 151(6), pp. 1192-1205, DOI: 10.1053/j.gastro.2016.09.001.
Article145 days agoDNA Methylation Profiling of Human Hepatocarcinogenesis
Gabriela Hernandez‐Meza, Johann von Felden, Edgar Gonzalez‐Kozlova, Teresa García‐Lezana, Judit Peix, Anna Portela, Amanda J. Craig, Sergi Sayols, Myron Schwartz, Bojan Losic, Vincenzo Mazzaferro, Manel Esteller, Josep M. Llovet, Augusto Villanueva (2020). DNA Methylation Profiling of Human Hepatocarcinogenesis. Hepatology, 74(1), pp. 183-199, DOI: 10.1002/hep.31659.
Article145 days agoRe-Expression of Fetal Igf2 as Epidriver and Target for Therapy in Hcc
Iris Martinez-Quetglas, Roser Pinyol, Daniel Dauch, Sara Torrecilla, Victoria Tovar, Agrin Moeini, Clara Alsinet, Silvana Bonilla, Anna Portela, Leonardo Rodríguez‐Carunchio, María A. Solé, A. Villanueva, Manel Esteller, Lars Zender, Josep M. Llovet (2016). Re-Expression of Fetal Igf2 as Epidriver and Target for Therapy in Hcc. Journal of Hepatology, 64(2), pp. S158-S158, DOI: 10.1016/s0168-8278(16)01663-9.
Article145 days ago466 IGF2 drives IGF oncogenic signaling in HCC and emerges as a potential target for therapies
I.M. Quetglas, Roser Pinyol, Daniel Dauch, Anna Portela, Alberto Villanueva, Judit Peix, María Ángeles Moreno de la Higuera, Agrin Moeini, Jessica Zucman‐Rossi, Manel Esteller, Vincenzo Mazzaferro, Lars Zender, Josep M. Llovet (2014). 466 IGF2 drives IGF oncogenic signaling in HCC and emerges as a potential target for therapies. European Journal of Cancer, 50, pp. 152-152, DOI: 10.1016/s0959-8049(14)70592-1.
Article145 days ago